title: Lifespan care in SCD: Whom to transition, the patients or the health care system?
authors.affiliation: Division of Hematology, Director, Sickle Cell Center, Montefiore Medical Center, 3411 Wayne Avenue, Suite A, Bronx, New York, USA.
authors.forename: Caterina P
authors.identifier: http://orcid.org/0000-0002-7059-2959
authors.initials: CP
authors.lastname: Minniti
authors.affiliation: UCSF Benioff Children's Hospital Oakland, 747 52nd Street, Oakland, CA, 94609, USA.
authors.forename: Elliott
authors.initials: E
authors.lastname: Vichinsky
mesh_terms: D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D019049:Developed Countries; D004502:Education, Medical, Continuing; D004636:Emergency Service, Hospital; D005260:Female; D006297:Health Services Accessibility; D006301:Health Services Needs and Demand; D006782:Hospitals, Special / Q000600:supply & distribution; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008017:Life Expectancy; D008297:Male; D008511:Medicine; D017410:Practice Guidelines as Topic; D060305:Transition to Adult Care; D014481:United States; D055815:Young Adult
chemical_list: D006918:Hydroxyurea